Holen Sie sich die Stockscreener-App
1.56
1.96%
0.03
Handel nachbörslich:
1.56
Evotec Se Adr Aktie (EVO) Neueste Nachrichten
Evotec stock heads into the open after a 1.4 percent gain - AD HOC NEWS
Evotec stock rises at the close after conference plans - AD HOC NEWS
Evotec stock falls as shares reach a new 52-week low - AD HOC NEWS
Evotec stock ends the day near 52-week low at the close on Nasdaq - AD HOC NEWS
Evotec stock gains as Frankfurt trading shows early rebound signs - AD HOC NEWS
Evotec at Morgan Stanley healthcare conference: push to clarify its story - Investing.com
Evotec SE (NASDAQ: EVO) Initiates First Human Trial for JST-018 Under 2023 Accelerated Antibodies Contract - kalkinemedia.com
Evotec starts Phase 1 trial for JST-018 antibody therapy - grafa.com
Drug Repurposing Market to Reach USD 50.91 Billion by 2035, Expanding at 3.93% CAGR | SNS Insider - GlobeNewswire Inc.
Evotec stock struggles after profit warning as Q2 2026 figures and guidance cuts weigh on sentiment - AD HOC NEWS
Evotec stock trades close to 52-week low as Q2 revenue declines - ad-hoc-news.de
Evotec stock trades at a discount to recent analyst targets as Xetra shares retreat - ad-hoc-news.de
Evotec stock trades well below analyst targets as selling pressure intensifies - Ad-hoc-news.de
Evotec stock faces earnings estimate cut as ADR trades below $2 - ad-hoc-news.de
Evotec AG Earnings Call: Weak 2026, Pipeline Hopes - The Globe and Mail
Evotec signs AI drug discovery partnership with Odyssey - grafa.com
Evotec SE (EVO) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesPost-Earnings Reaction - vinanet.vn
Berenberg cuts Evotec on delayed pharma deals clouding revenue outlook - Investing.com
Berenberg cuts Evotec stock rating on guidance downgrade By Investing.com - Investing.com Nigeria
Berenberg cuts Evotec stock rating on guidance downgrade - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
TD Cowen cuts Evotec on customer delays clouding growth outlook By Investing.com - Investing.com Nigeria
TD Cowen cuts Evotec on customer delays clouding growth outlook - Investing.com
H.C. Wainwright cuts Evotec stock price target on revenue guidance reduction - Investing.com
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Sahm
TD Cowen cuts Evotec stock rating on revenue delays, lowers target to $2 - Investing.com Nigeria
Earnings call transcript: Evotec cuts 2026 outlook as Q2 revenue falls - Investing.com Nigeria
Evotec slumps 32% after H1 loss widens, annual outlook slashed - Investing.com
Evotec stock. Thin source set keeps the focus on business context. - Ad Hoc News
EVTA Forecast — Price Target — Prediction for 2027 - TradingView
100% Profit Potential in Sight: Vidac Pharma's Chance to Double vs Bayer and Evotec - news.financial
Weight-Loss Injections, Cancer Cell Inhibitors & the Power of Algorithms: Adding Potential to Your Portfolio with Novo Nordisk, Vidac Pharma, and Evotec - news.financial
Evotec consensus picture on Wall Street, shares trade as ADR on NASDAQ - Ad-hoc-news.de
Evotec launches J.TRAIN for biologics manufacturing - grafa.com
Evotec consensus picture on Nasdaq EVO, shares hover around 2.74 dollars - ad-hoc-news.de
A0QZ3J Forecast — Price Target — Prediction for 2027 - TradingView
Evotec SE Sponsored ADR Actuals & Estimates (NASDAQ:EVO) - TradingView
Evotec refines analyst expectations, shares trade under 5 euros on Xetra - AD HOC NEWS
Evotec shows weak June performance, analyst consensus points above current shares - AD HOC NEWS
Evotec Stockweekly review and sector comparison - Ad-hoc-news.de
Which stock to buy now? Evotec, Nel, and Lahontan Gold in focus - news.financial
Evotec (EVO) Stock Price, News & Analysis $EVO - MarketBeat
Evotec SE Stock (DE0005664809): Short Interest Eases While Shares Trade Near Lows - AD HOC NEWS
Earnings call transcript: Evotec Q1 2026 sees revenue drop amid market challenges - Investing.com
Evotec Q1 2026 slides: revenue drops 22% as transformation accelerates - Investing.com
Evotec reports wider quarterly loss, misses revenue expectations By Investing.com - Investing.com Nigeria
Evotec SE stock (DE0005664809): After CEO exit and audit delay, investors watch turnaround plans - AD HOC NEWS
EVO - Finviz
Evotec ADR Slides 4.3% as Selling Pressure Tests Key Support LevelsQuality Factor - The Legal Advocate
Takeover Candidates for 2026! The Life Sciences Sector Is Heating Up: Evotec, BioNxt Solutions, BioNTech, and Formycon in Focus! - news.financial
BUY RECOMMENDATIONS for RENK and Desert Gold! SHOCK for Evotec! - news.financial
Evotec SE stock (DE0005664809): Steady FY 2025 results amid US expansion - AD HOC NEWS
Evotec AG Earnings Call Balances Pain With Promise - The Globe and Mail
Evotec SE stock (DE0005664809): Drug discovery leader eyes US biotech growth - AD HOC NEWS
Evotec places €116.1 million convertible bonds due 2033 - Investing.com UK
0.18%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):